Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences
ZUG, Switzerland, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Phase 2 ACUITY trial…
Boehringers HERNEXEOS approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
This press release is not intended for UK and US media. HERNEXEOS® (zongertinib…
Anavar For Women And Men: CrazyBulk Launch Anavar Legal Steroid Alternative For Female Read Dosage, Side Effects, (Before and After Cycle results)
New York, Aug. 31, 2025 (GLOBE NEWSWIRE) -- August 31, 2025 |…
FY Energy Launches Multi-Level Affiliate Program to Expand Access to Clean-Powered Crypto Infrastructure
New York City, NY, Aug. 31, 2025 (GLOBE NEWSWIRE) -- FY Energy,…
FY Energy Expands Green Energy Cloud Computing Contracts to Support Low-Carbon Blockchain Infrastructure
New York City, NY, Aug. 31, 2025 (GLOBE NEWSWIRE) -- As the…
FY Energy Upgrades ETH Cloud Infrastructure for Passive Income Through Cloud Computing as Billions Shift Away from Bitcoin
New York City, NY, Aug. 31, 2025 (GLOBE NEWSWIRE) -- As a…
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025
-- Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanisms of Action --…
Novo Nordisks Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease
Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater…
KFSHRC Strengthens Its Position as a Fast-Growing Destination for International Patients
RIYADH, Saudi Arabia, Aug. 30, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist…
FY Energy Launches BTC Cloud Computing Contracts Backed by Green Energy as Institutional Demand Surges
New Jersey City, Aug. 30, 2025 (GLOBE NEWSWIRE) -- Amid growing institutional…
